The Lung Cancer Channel is supported with funding from Johnson & Johnson (Gold) and Takeda (Gold).
VJOncology is an independent medical education platform. Supporters, including channel supporters, have no influence over the production of content. The levels of sponsorship listed are reflective of the amount of funding given to support the channel.
ISLB 2022 | Challenges to be overcome in liquid biopsy
Amy Moore, PhD, Lungevity Foundation, USA, discusses three key challenges that need to be overcome in liquid biopsy: the improvement of education and awareness of liquid biopsy among both patients and physicians, the improvement of access to liquid biopsy, and the addressing of cost issues. This interview took place at the International Society of Liquid Biopsy (ISLB) 2022 congress in Miami, FL.
These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.
Disclosures
Advisory Board: Bayer, Pfizer, Novartis, Exact Sciences, Jazz Pharmaceuticals, Debiopharm
